Achieve Life Sciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -57 | -57 | -57 |
EBITDA | -7,600 | -5,624 | -4,632 |
EBIT | -7,657 | -5,681 | -4,689 |
Net Income | -8,461 | -6,494 | -5,476 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -4,921 | -5,288 | -4,370 |
Cash | 14,756 | 66,397 | 15,546 |
Basic Shares | 34,318 | 25,048 | 21,165 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -228 | -236 | -250 | -255 |
EBITDA | -26,734 | -40,564 | -32,844 | -14,475 |
EBIT | -26,962 | -40,800 | -33,094 | -14,730 |
Net Income | -29,815 | -41,875 | -32,902 | -14,661 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -18,254 | 19,189 | ||
Free Cash Flow | -24,500 | -37,549 | -29,457 | -13,491 |
Cash | 15,546 | 24,771 | 43,022 | 35,853 |
Basic Shares | 19,827 | 10,593 | 8,119 | 2,718 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.36 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.26 |
2023-12-31 | -$0.26 |
